HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats
Qie Shi(Zhejiang Academy of Medical Sciences), Erfan Wei(Zhejiang University), SA Xiao-ying(Zhejiang Academy of Medical Sciences), Xiaolei Song(Zhejiang Academy of Medical Sciences), W.P. Zhang(Zhejiang University), Huazhong Ying(Hangzhou Medical College), Yun‐Bi Lu(Institute of Plant Protection), Zhibin Liu(Zhejiang University), S.H. Fang(Zhejiang University), H. Wang(Tongde Hospital of Zhejiang Province)
Cited by 62
Related Papers
PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics
|Molecular Medicine Reports|2017|237
Comprehensive human proteome profiles across a 50-year lifespan reveal aging trajectories and signatures
|Cell|2025|126
Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils
|Food and Chemical Toxicology|2012|108
Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis
|Biomedicine & Pharmacotherapy|2023|98
New Epigallocatechin Gallate (EGCG) Nanocomplexes Co-Assembled with 3-Mercapto-1-Hexanol and <i>β</i>-Lactoglobulin for Improvement of Antitumor Activity
|Journal of Biomedical Nanotechnology|2017|68